Patents Assigned to Vavotar Life Sciences LLC
  • METHODS OF TREATING TRIPLE-NEGATIVE BREAST CANCER USING COMPOSITIONS OF ANTIBODIES AND CARRIER PROTEINS
    Publication number: 20210275490
    Abstract: Described herein are methods, formulations and kits for treating a patient with triple-negative breast cancer with nanoparticle complexes comprising a carrier protein (e.g., albumin), paclitaxel and a binding agent specific for a target antigen expressed by the cells (e.g., an anti-VEGF antibody).
    Type: Application
    Filed: September 5, 2017
    Publication date: September 9, 2021
    Applicants: Mayo Foundation for Medical Education and Research, Vavotar Life Sciences LLC
    Inventors: Gerald F. SWISS, Jesse CROWNE, Svetomir N. MARKVOIC, Wendy K. MEVALA
  • Methods of treating cancer using compositions of antibodies and carrier proteins with antibody pretreatment
    Patent number: 10561726
    Abstract: Described herein are methods, formulations and kits for treating a patient with cancer with anti-VEGF antibodies and albumin-bound chemotherapeutic/anti-VEGF antibody nanoparticle complexes.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: February 18, 2020
    Assignees: Vavotar Life Sciences LLC, Mayo Foundation for Medical Education and Research
    Inventors: Gerald F. Swiss, Svetomir N. Markovic, Wendy K. Nevala